Nektar Therapeutics Reports Fourth Quarter and Year-End 2015 Financial Results

Go back to Nektar Therapeutics Reports Fourth Quarter and Year-End 2015 Financial Results
Nektar Therapeutics (NASDAQ: NKTR) Delayed: 66.26 +1.87 (2.90%)
Previous Close $64.39    52 Week High $19.98 
Open $65.03    52 Week Low $10.52 
Day High $66.83    P/E N/A 
Day Low $64.97    EPS $-1.45 
Volume 349,521